Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin.
Schiffelers RM, Koning GA, ten Hagen TL, Fens MH, Schraa AJ, Janssen AP, Kok RJ, Molema G, Storm G.
Schiffelers RM, et al. Among authors: ten hagen tl.
J Control Release. 2003 Aug 28;91(1-2):115-22. doi: 10.1016/s0168-3659(03)00240-2.
J Control Release. 2003.
PMID: 12932643